News

 

12.17.2010 Burns Opines on the Likelihood of Supreme Court Review in "Reverse Payment" Patent Settlement Antitrust Case Jim Burns was quoted in the December 17 issue of the BNA Pharmaceutical Law and Industry Reporter. In an article entitled "Drug Purchasers Urge Supreme Court to Hear Reverse Payments Case," he opined that the Supreme Court might well accept the case for review, given that the circuit courts have issued conflicting rulings regarding whether such settlements should be considered unlawful under the antitrust laws.

A copy of the Dec. 17 issue of the BNA Pharmaceutical Law and Industry Reporter, including the article in which Jim Burns is quoted, can be accessed by clicking on the attached file.